; and (B) relevant to the performance of such pharmacy based on the type of pharmacy (including retail, mail order, specialty, long-term care, and home infusion or other types of pharmacies), drugs dispensed, and pharmacy services used to dispense and manage drugs. (2) Standardized pharmacy performance measures (A) Measures (i) In general Notwithstanding any other provision of law, the Secretary shall establish (or adopt pursuant to clause (iii)) standardized pharmacy performance measures to be used by a PDP sponsor offering a prescription drug plan and an MA organization offering an MA–PD plan for the purpose of determining incentive payments, price concessions, or fees described in paragraph (1). (ii) Requirements The measures under clause (i) shall focus on pharmacy performance and quality of care based on the type of pharmacy, as determined by the Secretary. Such measures shall be evidence-based, feasible, appropriate and reasonable. The Secretary may rely on data and information collected from relevant stakeholders to make determinations about whether a measure satisfies the requirements of this clause. (iii) Adoption of measure In lieu of establishing some or all of the measures under this paragraph, the Secretary may adopt measures and measure performance criteria that are endorsed by 1 or more multi-stakeholder consensus organizations (such as the Pharmacy Quality Alliance), that has participation from pharmacies (including retail and specialty pharmacies not owned or affiliated with a plan, pharmacy benefit manager, or other pharmacy), health plans, pharmacy benefit managers, and the Centers for Medicare & Medicaid Services. Any measure adopted under this clause shall be deemed to meet the requirements under clause (ii). (B) Maintenance of list (i) In general The Secretary shall maintain, and publish on a publicly available internet website, a list of measures established or adopted under this paragraph. Such list shall initially be published no later than June 1, 2024. (ii) Update The Secretary shall